Market revenue in 2023 | USD 236.1 million |
Market revenue in 2030 | USD 354.0 million |
Growth rate | 6% (CAGR from 2023 to 2030) |
Largest segment | Peripheral stents |
Fastest growing segment | Plaque Modification Devices |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | PTA Balloons, Catheters, Endovascular Aneurysm Repair Stent Grafts, Plaque Modification Devices, Peripheral Accessories, Inferior Vena Cava Filters, Hemodynamic Flow Alteration Devices, Peripheral Stents |
Key market players worldwide | Abbott Laboratories, Edwards Lifesciences Corp, Medtronic PLC, St. Jude Medical, Teleflex Inc, Philips, Boston Scientific Corp, Cook Group, Covidien, AngioScore |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to peripheral vascular devices market will help companies and investors design strategic landscapes.
Peripheral stents was the largest segment with a revenue share of 21.9% in 2023. Horizon Databook has segmented the Spain peripheral vascular devices market based on pta balloons, catheters, endovascular aneurysm repair stent grafts, plaque modification devices, peripheral accessories, inferior vena cava filters, hemodynamic flow alteration devices, peripheral stents covering the revenue growth of each sub-segment from 2018 to 2030.
Spain has a resilient healthcare infrastructure marked by a comprehensive array of public and private medical institutions. The spatial distribution of healthcare facilities across various regions is expected to improve the accessibility of peripheral vascular procedures. Increasing clinical studies and research in PAD and peripheral vascular diseases are driving the growth of peripheral vascular devices market.
Increasing research efforts have yielded breakthroughs in discovering novel technologies and treatment modalities for peripheral vascular diseases. The identification of existing treatment gaps by researchers has catalyzed the advancement of innovative peripheral vascular devices. For instance, in November 2022, Shockwave Medical, Inc. announced the conclusive findings from the Disrupt PAD III Observational Study, encompassing a cohort of 1,373 patients.
The analysis highlighted the consistent efficacy of IVL (Intravascular Lithotripsy) in managing intricate and challenging lesions across diverse peripheral vessel beds. This study is the most extensive prospective "real-world" evidence supporting IVL as a viable treatment for complex, heavily calcified PAD. The comprehensive results were presented at VIVA22 during a late-breaking clinical trial session. Such initiatives are boosting the industry growth in the near future.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain peripheral vascular devices market, including forecasts for subscribers. This country databook contains high-level insights into Spain peripheral vascular devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account